ISDS Case Map
CPTPP
Comprehensive and Progressive Agreement for Trans-Pacific Partnership
The United States and eight other Asia Pacific countries agreed on Thursday to strive for the "broad outlines" of a free trade pact by the time President Barack Obama hosts a regional summit in Hawaii in November.
A group of 28 US Senators has written President Obama urging his administration to include “the highest level of IP protections” in the Trans Pacific Partnership.
Japan has finally admitted it will not be able to decide by next month whether it should join the emerging US-backed trade bloc, the Trans Pacific Partnership.
Trade Minister Tim Groser is optimistic key elements of the Trans-Pacific Partnership (TPP) agreement will be hammered out at a meeting of Apec trade ministers in the United States this week.
Trade and Industry Minister Lim Hng Kiang said Singapore's negotiations for Free Trade Agreements with the European Union and the nine-member Trans-Pacific Partnership (TPP) are progressing well since talks began last year.
The government should promptly decide to join the Trans-Pacific Partnership agreement and implement bold agricultural reforms in the disaster-hit Tohoku region, writes the Yomiuri Shimbun
Some of New Zealand's most prominent businesspeople are rallying to the support of drug buying body Pharmac as lobbying firm Saunders Unsworth mounts a campaign against the agency ahead of free trade negotiations with the US.
The controversial Trans Pacific Partnership Agreement (TPPA) is under fire over human rights issues.
Representatives from Australia's internet industry have called for full disclosure of a proposed free trade agreement between the United States and its allies in the Pacific, concerned that the deal asks ISPs to shoulder onerous burdens around copyright infringement.
US pharmaceutical industry association the Pharmaceutical Research and Manufacturers of America is calling on the US Trade Representative to include strong intellectual property provisions, such as 12-year data protection for follow-on biologics, in the Trans-Pacific Partnership agreement.
